審査 against 独立行政法人医薬品医療機器総合機構

独立行政法人医薬品医療機器総合機構 (医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律)
医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律Ministry of Health, Labour and Welfare

Action summary

Company
Original: 独立行政法人医薬品医療機器総合機構
Governing law
医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律
医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律
Action type
審査
審査
Action date
Unknown
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

For items designated under the Priority Review System, the review is conducted with the aim of 6 months, utilizing the preliminary evaluation conducted by the Pharmaceuticals and Medical Devices Agency (PMDA).

Show original Japanese text

先駆け審査指定制度の対象品目に指定された品目については、PMDAが行う事前評価を活用しつつ6ヶ月を目標に審査を行う。

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when 独立行政法人医薬品医療機器総合機構 has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
独立行政法人医薬品医療機器総合機構 Japanese only
Japanese name
独立行政法人医薬品医療機器総合機構
Registered address
東京都千代田区霞が関3丁目3番2号
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.